7446
TOHOKU CHEMICAL CO., LTD.
東北化学薬品株式会社Tohoku Chemical Co., Ltd., a trading company, sells pharmaceuticals, pesticides, food additives, and industrial chemicals and reagents in Japan. The company operates through Medical, Academia, and Life Sciences segments. The company offers chemical industrial reagents/chemical industrial reagent-related apparatus. It also provides clinical diagnostic reagents/clinical diagnostic reagent-related equipment, such as kits inspecting for blood or bacteria helpful for medical examination and diagnosis of various diseases; medical devices that include clinical inspection apparatus and medical imaging systems; and external body diagnosing medicines, medical devices, medical materials, etc. In addition, the company offers food additives/food processing apparatus; and reagents for product inspection analysis, hygiene materials, detergents, pesticides, and water treatment, as well as materials for transfer, analytical inspection, and product development. Further, the company offers agricultural materials, such as pesticides, soil improvement materials, fertilizer, seedling, gardening material, and agriculture-related materials; steel greenhouses for floriculture; and healthcare products. Additionally, it engages in the sale and repair of computers, scientific instruments, medical equipment, educational devices, and measuring equipment; cultivation and sale of flowers; and multifunctional-home care business. Tohoku Chemical Co., Ltd. was incorporated in 1953 and is headquartered in Hirosaki, Japan.
Price
¥4,600
Market Cap
¥4.1B
Ent. Value
¥3.6B
Net Cash
¥574M
Shares Out.
0.9M
P / E
9.7×
EV / EBIT
6.9×
⚠ TSE Capital Mandate
P / Book
0.52×
P / NCAV
1.71×
Div. Yield
2.72%
Financials
| Metric |
FY 2025
EDINET ↗ |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|---|
| Net Sales | ¥34.4B | ¥32.2B | ¥35.1B | ¥37.3B | ¥36.2B |
| Cost of Sales | ¥31.2B | ¥29.0B | ¥31.8B | ¥33.9B | ¥33.0B |
| Gross Profit | ¥3.3B | ¥3.1B | ¥3.3B | ¥3.5B | ¥3.2B |
| SG&A | ¥2.8B | ¥2.8B | ¥2.6B | ¥2.5B | ¥2.5B |
| Operating Income | ¥518M | ¥353M | ¥751M | ¥944M | ¥713M |
| Non-Operating Income | ¥85M | ¥76M | ¥67M | ¥64M | ¥50M |
| Dividend Income | ¥58M | ¥49M | ¥43M | ¥36M | ¥27M |
| Interest Income | ¥7M | ¥3M | ¥4M | ¥3M | ¥3M |
| Non-Operating Expenses | ¥8M | ¥21M | ¥10M | ¥5M | ¥4M |
| Interest Expense | ¥4M | ¥3M | ¥2M | ¥2M | ¥1M |
| Ordinary Income | ¥595M | ¥408M | ¥808M | ¥1.0B | ¥759M |
| Pre-tax Income | ¥639M | ¥380M | ¥805M | ¥975M | ¥748M |
| Income Taxes | ¥207M | ¥141M | ¥238M | ¥293M | ¥211M |
| Current Tax | ¥233M | ¥158M | ¥237M | ¥293M | ¥213M |
| Deferred Tax | ¥-26M | ¥-17M | ¥1M | ¥0M | ¥-2M |
| Net Income (owners) | ¥429M | ¥237M | ¥556M | ¥658M | ¥517M |
| Minority Interest | ¥3M | ¥2M | ¥10M | ¥24M | ¥21M |
| Comprehensive Income | ¥607M | ¥333M | ¥691M | ¥493M | ¥780M |
| EBITDA | ¥684M | ¥522M | ¥831M | ¥1.0B | ¥806M |
| EPS | ¥475.93 | ¥263.54 | ¥617.29 | ¥728.76 | ¥564.91 |
| Shares Outstanding | 0.9M | 0.9M | 0.9M | 0.9M | 0.9M |
| Shares Issued (total) | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Treasury Shares | 0.1M | 0.1M | 0.1M | 0.1M | 0.0M |